TY - JOUR
T1 - Defining language disorders in children and adolescents with Noonan Syndrome
AU - Lazzaro, Giulia
AU - Caciolo, Cristina
AU - Menghini, Deny
AU - Cumbo, Francesca
AU - Digilio, Maria C.
AU - Capolino, Rossella
AU - Zampino, Giuseppe
AU - Tartaglia, Marco
AU - Vicari, Stefano
AU - Alfieri, Paolo
N1 - Funding Information:
The authors thank all patients and their families for their participation in the study. This work was supported in part by E-Rose (?NSEuroNet, to M.T.), and the Italian Ministry of Health (Ricerca Corrente, to S.V and M.T.).
Publisher Copyright:
© 2019 The Authors. Molecular Genetics & Genomic Medicine published by Wiley Periodicals, Inc.
Copyright:
Copyright 2020 Elsevier B.V., All rights reserved.
PY - 2020/4/1
Y1 - 2020/4/1
N2 - Background: Noonan Syndrome is a developmental disorder characterized by a distinctive phenotype including facial dysmorphism, webbed neck, short stature, heart defects, and variable cognitive deficits as major features. Over the years, neuropsychological and behavioral studies explored alteration of cognitive functioning and related domains, such as learning, memory, and attention. To our knowledge, however, data concerning the language profile in this disorder is scarce. The aim of the present study was to detect specific language functioning combining nonverbal intelligence quotient and language abilities and to pinpoint strengths and weaknesses in the language domains. Methods: The language profile of 37 Italian participants with molecularly confirmed diagnosis of Noonan Syndrome was evaluated using specific tools to assess vocabulary and grammar comprehension and production, as well as phonological development. Results: We observed that 78% of affected individuals exhibited language impairment. Within language domains, the strong area was lexical production and grammar production was the weak area. Almost half the participants manifested a similar trend of specific language impairment. Nonverbal intelligence quotient only correlated with grammar comprehension. Conclusion: Our study expands present knowledge about the language profile in NS, and provides data that could enable more effective patient management and appropriate intervention.
AB - Background: Noonan Syndrome is a developmental disorder characterized by a distinctive phenotype including facial dysmorphism, webbed neck, short stature, heart defects, and variable cognitive deficits as major features. Over the years, neuropsychological and behavioral studies explored alteration of cognitive functioning and related domains, such as learning, memory, and attention. To our knowledge, however, data concerning the language profile in this disorder is scarce. The aim of the present study was to detect specific language functioning combining nonverbal intelligence quotient and language abilities and to pinpoint strengths and weaknesses in the language domains. Methods: The language profile of 37 Italian participants with molecularly confirmed diagnosis of Noonan Syndrome was evaluated using specific tools to assess vocabulary and grammar comprehension and production, as well as phonological development. Results: We observed that 78% of affected individuals exhibited language impairment. Within language domains, the strong area was lexical production and grammar production was the weak area. Almost half the participants manifested a similar trend of specific language impairment. Nonverbal intelligence quotient only correlated with grammar comprehension. Conclusion: Our study expands present knowledge about the language profile in NS, and provides data that could enable more effective patient management and appropriate intervention.
KW - IQ
KW - Linguistic functioning
KW - PTPN11
KW - RASopathies
KW - SLI
UR - http://www.scopus.com/inward/record.url?scp=85079468579&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85079468579&partnerID=8YFLogxK
U2 - 10.1002/mgg3.1069
DO - 10.1002/mgg3.1069
M3 - Article
C2 - 32059087
AN - SCOPUS:85079468579
VL - 8
JO - Molecular genetics & genomic medicine
JF - Molecular genetics & genomic medicine
SN - 2324-9269
IS - 4
M1 - e1069
ER -